7- O -Malonyl Macrolactin A, a New Macrolactin Antibiotic from Bacillus subtilis Active against Methicillin-Resistant Staphylococcus aureus , Vancomycin-Resistant Enterococci, and a Small-Colony Variant of Burkholderia cepacia
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
We report here the discovery, isolation, and chemical and preliminary biological characterization of a new antibiotic compound, 7- O -malonyl macrolactin A (MMA), produced by a Bacillus subtilis soil isolate. MMA is a bacteriostatic antibiotic that inhibits a number of multidrug-resistant gram-positive bacterial pathogens, including methicillin-resistant Staphylococcus aureus , vancomycin-resistant enterococci, and a small-colony variant of Burkholderia cepacia . MMA-treated staphylococci and enterococci were pseudomulticellular and exhibited multiple asymmetric initiation points of septum formation, indicating that MMA may inhibit a cell division function.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility
Hiramatsu, K. (1997) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/40.1.135 · Cited by 1,984 · cited 2×
“S. aureus organisms intermediately susceptible to vancomycin were first isolated in 1997 in Japan (15) and later in other countries (8).”
Yakimov, M. M., Golyshin, P. N., Lang, S., Moore, E. R. B., Abraham, W.-R., Lunsdorf, H., & Timmis, K. N. (1998) · International Journal of Systematic Bacteriology · doi:10.1099/00207713-48-2-339 · Cited by 597
Self-citation
Cited by
Chen, X. H., Koumoutsi, A., Scholz, R., Eisenreich, A., Schneider, K., Heinemeyer, I., Morgenstern, B., Voss, B., Hess, W. R., Reva, O., et al. (2007) · Nature Biotechnology · doi:10.1038/nbt1325 · Cited by 873
Overview of the Antimicrobial Compounds Produced by Members of the Bacillus subtilis Group
Caulier, S., Nannan, C., Gillis, A., Licciardi, F., Bragard, C., & Mahillon, J. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.00302 · Cited by 817
Bacillus velezensis: A Valuable Member of Bioactive Molecules within Plant Microbiomes
Rabbee, M. F., Ali, M. S., Choi, J., Hwang, B. S., Jeong, S. C., & Baek, K.-H. (2019) · Molecules · doi:10.3390/molecules24061046 · Cited by 550
“9 Direct suppression Bacteria [30,54] Nonribosomal synthesis of dipeptide antibiotics Bacilysin bacABCDE, ywfG NRPS 6.”
BackgroundBiosynthesis of polyketides by trans-AT polyketide synthases
Helfrich, E. J. N., & Piel, J. (2016) · Natural Product Reports · doi:10.1039/c5np00125k · Cited by 478
Chen, X. H., Koumoutsi, A., Scholz, R., Schneider, K., Vater, J., Süssmuth, R., Piel, J., & Borriss, R. (2009) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2008.10.011 · Cited by 467
Metadata
- Authors
- Romero-Tabarez, M., Jansen, R., Sylla, M., Lünsdorf, H., Häußler, S., Santosa, D. A., Timmis, K. N., & Molinari, G.
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 2006-05
- Volume
- 50
- Issue
- 5
- Pages
- 1701-1709
- ISSN
- 0066-4804 (ISSN-L)
- 1098-6596
- OpenAlex
- W1999648831
- Cited by
- 148
- References
- 2
- FWCI
- 3.77
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: 7- O -Malonyl Macrolactin A, a New Macrolactin Antibiotic from Bacillus subtilis Active against Methicillin-Resistant Staphylococcus aureus , Vancomycin-Resistant Enterococci, and a Small-Colony Variant of Burkholderia cepacia. https://app.cochat.ai/papers/10.1128/aac.50.5.1701-1709.2006
- The paper
- Romero-Tabarez, M., Jansen, R., Sylla, M., Lünsdorf, H., Häußler, S., Santosa, D. A., Timmis, K. N., & Molinari, G. (2006). 7- O -Malonyl Macrolactin A, a New Macrolactin Antibiotic from Bacillus subtilis Active against Methicillin-Resistant Staphylococcus aureus , Vancomycin-Resistant Enterococci, and a Small-Colony Variant of Burkholderia cepacia. Antimicrobial Agents and Chemotherapy. https://doi.org/10.1128/aac.50.5.1701-1709.2006
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.